JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹209 Cr | ₹237 Cr | ₹218 Cr | ₹188 Cr | ₹159 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹209 Cr |
Mar2023 | ₹237 Cr |
Mar2022 | ₹218 Cr |
Mar2021 | ₹188 Cr |
Mar2020 | ₹159 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹209 Cr | -11.83 | |
Mar2023 | ₹237 Cr | 8.79 | |
Mar2022 | ₹218 Cr | 15.77 | |
Mar2021 | ₹188 Cr | 18.53 | |
Mar2020 | ₹159 Cr | - |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,427.9 Cr | -0.4% | 2.2% | 93.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | -0.4% |
2.2% |
93.5% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses